Protalix Biotherapeutics, Inc. (de) · AMEX:PLX
MAK Capital Fund LP's stake in Protalix Biotherapeutics, Inc. (de) fell to 4.50% (Schedule 13G/A)
Event Mar 24, 2026 · Filed Mar 30, 2026
MAK Capital Fund LP's stake in Protalix Biotherapeutics, Inc. (de) fell to 4.50%, 3,616,289 shares, as a passive investor on Mar 24, 2026. Filed Mar 30, 2026 (Schedule 13G/A).
- Stake
- 4.50%
- Shares
- 3,616,289
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| MAK Capital Fund LP | 4.50% | 3,616,289 |
| MAK CAPITAL ONE LLC | 4.50% | 3,616,289 |
| Kaufman Michael A | 4.50% | 3,616,289 |